MDL | MFCD29904545 |
---|---|
Molecular Weight | 1589.67 |
Molecular Formula | C75H112O36 |
SMILES | OC[C@](C([C@]1([H])CC2(C)C)=CC[C@]3([H])[C@]4(C[C@@H]5O)C)(CC[C@]1(CC2)C(O[C@H](O[C@@H]6C)[C@@H]([C@H]([C@H]6OC(/C=C/C(C=C7OC)=CC(OC)=C7OC)=O)O)O[C@H](O[C@H]8C)[C@@H]([C@@H]([C@H]8O[C@H](OC[C@H]9O)[C@@H]([C@H]9O[C@H](OC[C@@H]%10O)[C@@H]([C@H]%10O)O)O)O[C@H](OC[C@@](O)%11CO)[C@@H]%11O)O)=O)[C@@]3(CC[C@@]4([H])[C@@](C)([C@H]5O[C@@H]([C@@H]([C@H]%12O)O)O[C@@H]([C@H]%12O)CO)C(O)=O)C |
Polygalasaponin XXXI (Onjisaponin F) is an effective adjuvant for intranasal administration of influenza Influenza hemagglutinin (HA) vaccine to protect influenza virus infection [1] .
Polygalasaponin XXXI (Onjisaponin F) also enhances anti-HA IgA and IgG Ab titers in the nasal wash, whereas Onjisaponins E and G enhances only anti-HA IgA Ab titer significantly. Polygalasaponin XXXI can induce protective immunity against intranasal infection by influenza virus
[1]
.
Polygalasaponin XXXI (Onjisaponin F) (1 or 10 µg/mL) also induces ChAT mRNA level in rat basal forebrain cells
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Intranasal vaccination with Polygalasaponin XXXI (Onjisaponin F) inhibits proliferation of mouse adapted influenza virus A/PR/8/34 in bronchoalveolar lavages of infected mice [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)